Where we are at now20 Nov 2020 10:07
6 weeks until the end of the yr.
2019 rev $6.8mln, that included a stand alone order of $1.1mln.
As there has been no rns to indicate any single orders of $750k or more, there have been no orders for this amount, this we can say for certain.
So I am working on a revenue assumption of $5.7mln, this emulates the rest of the sales of 2019, which given the trading update may be overly generous, but is the figure I work with.
SaaS payments are up also, so i think a fair revenue figure to work with is $6mln. over the years r n d has been pretty constant at approx $230k, albeit you could argue that with new afflictions may have affected that, but that would be speculation.
Those figures are about the same as the 2018 revenues ($6mln), which produced a EBITDA of negative $193k for the year and a net loss of $1.3mln overall
After the last set of accounts there was $158k in cash and the BoD loaned the company $243k. total cash was $403k after the loan
The real question is, are the revenues at an equivalent amount as the previous year, given the disruption in trading? Form your own opinion on that, it depends on whether you are positive or negative currently.
These figures are taken from the accounts and represent the trading, so best case I reckon $200k in cash currently given the EBITDA. With a tax bill due in may, which they are looking to defer
The banking facility is only really useful for bigger orders, it gives the facility to get all of the raw materials with capital raising, until pymts are received. If this is used ultimately it reduces the profitability of all deals given the extra interest that accrues, so I hope that it has been used sparingly given the cash position
I think that this is a fair analysis of the current position.....
Sign In
Follow the stocks
